Colon Cancer Test Information
Reliable colon cancer test options are provided at Moffitt Cancer Center. As a high-volume cancer center, our physicians have ample experience screening, diagnosing and treating all types of colorectal cancers. We provide colonoscopies and other screening services to patients who want to be proactive about their colon health.
A colon cancer test can detect the earliest signs of cancerous activity, long before it causes any noticeable symptoms. And, as with most other cancers, an early diagnosis can lead to a better prognosis and quality of life. Screening can also detect benign (noncancerous) polyps that can eventually become cancerous.
It is recommended that individuals between the ages of 50 and 75 undergo regular colon cancer screening. However, people with certain risk factors are encouraged to begin screening at a younger age. Some factors that warrant colon cancer testing include:
- Having a personal or family history of colon polyps or colorectal cancer
- Being African AmericanÂ
- Having certain inherited syndromes, such as Lynch syndrome and adenomatous polyposisÂ
- Having inflammatory intestinal diseases, such as Crohn’s disease and ulcerative colitis
In the event that a colon cancer screening shows signs of malignancy, Moffitt’s Gastrointestinal Oncology Program provides comprehensive treatment from a multispecialty team of medical oncologists, radiologists, surgeons, radiation oncologists and other medical experts and supportive care professionals, all of whom specializing in the diagnosis and treatment of colon cancer.
If you’d like to receive a colon cancer test at Moffitt, call 1-888-663-3488 or complete a new patient registration form. Referrals are not required to visit Moffitt.
Colon Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer